MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Melanoma, Experimental

(UMLS:C0025205)

Definition:: Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.
UMLS ID:: C0025205
MeSH ID:: D008546

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.650.510.525|C04.557.580.625.650.510.525|C04.557.665.510.525|C04.619.600

Classification 2:

Name:

Investigative Techniques
MeSH Tree Number(s):: E05.598.500.496.937

Synonym(s)

Melanoma, Experimental

Experimental Malignant Melanoma

Experimental Melanoma

Associated Drug(s)

	Name	Reference(s)	Data Source
1	2-oxothiazolidine-4-carboxylic acid	10803710	CTD
2	4-N-bis(2-chloroethyl)aminobenzoic acid	24287558	CTD
3	4-hydroxycoumarin	18492274	CTD
4	4-methoxytranylcypromine	29438700	CTD
5	5-carboxy-8-hydroxyquinoline	29438700	CTD
6	9-(tetrahydro-2-furyl)-adenine	29179997	CTD
7	Acetaminophen	19513568	CTD
8	Acrolein	10803710	CTD
9	Arsenicals	30428081	CTD
10	Cyclophosphamide	16388313	CTD
11	Cysteine	25205294	CTD
12	Fluorouracil	25936796	CTD
13	Gallic Acid	19577552	CTD
14	Losartan	19771429	CTD
15	Lovastatin	30662405	CTD
16	Maloprim	18593930	CTD
17	Melphalan	24287558	CTD
18	Paclitaxel	1359143	CTD
19	Resveratrol	25936796	CTD
20	Sirolimus	19922502	CTD
21	Testosterone	18336327	CTD
22	beta-ionone	9164984	CTD
23	diallyl trisulfide	25205294	CTD
24	geraniol	1988098 7472655	CTD
25	octacosane	24991116	CTD
26	plastochromanol 8	9164984	CTD
27	tocotrienol, delta	30662405	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Hutchinson's Melanotic Freckle	50.2%
2	Melanoma, Amelanotic	50.2%
3	Leukemia, Experimental	39.6%
4	Neoplasms, Neuroepithelial	38.9%
5	Gliomatosis cerebri	38.9%
6	Adenoma, Acidophil	35.4%
7	Sarcoma, Experimental	35.3%
8	Neurilemmoma	34.5%
9	Mammary Neoplasms, Experimental	33.4%
10	Carcinoid Tumor	33.3%
11	Paraganglioma	31.9%
12	Craniopharyngioma	31.1%
13	Neuroectodermal Tumor, Melanotic	31.1%
14	Carcinoma 256, Walker	28.5%
15	Medulloblastoma	27.7%
16	leukemia	26.7%
17	Neoplasms, Glandular and Epithelial	26.7%
18	Meningioma	26.6%
19	Carcinoma, Ehrlich Tumor	26.4%
20	Carcinoma, Lewis Lung	26.4%
21	Ganglioneuroma	25.7%
22	Glioma	25.7%
23	Malignant Glioma	25.7%
24	Liver Neoplasms, Experimental	25.4%
25	Malignant Carcinoid Syndrome	24.5%
26	Trophoblastic Neoplasms	24.4%
27	Pheochromocytoma	23%
28	Histiocytic Disorders, Malignant	22.9%
29	Nevus	22.1%
30	Carcinosarcoma	21.9%
31	Hemangiosarcoma	21.9%
32	lymphangiosarcoma	21.9%
33	Dermoid Cyst	21.2%
34	Hamartoma	21.1%
35	Neoplasms, Hormone-Dependent	21.1%
36	Neoplasms, Multiple Primary	21.1%
37	Paraneoplastic Syndromes	21.1%
38	Precancerous Conditions	21.1%
39	Neoplasms, Second Primary	21.1%
40	Composite Lymphoma	20.7%
41	Leukemia L1210	20.5%
42	Leukemia P388	20.5%
43	Chordoma	20.4%
44	Teratoma	20.4%
45	Germinoma	20.4%
46	Teratocarcinoma	20.4%
47	Neuroectodermal Tumors	20.4%
48	Lymphoma	20.1%
49	Retinoblastoma	19.9%
50	Neoplasms, Germ Cell and Embryonal	19.7%
51	Germ Cell Cancer	19.7%
52	Leukemia, Plasma Cell	19.1%
53	Astrocytoma	19.1%
54	Ependymoma	19.1%
55	oligodendroglioma	19.1%
56	Ganglioglioma	19.1%
57	gliosarcoma	19.1%
58	Anaplastic astrocytoma	19.1%
59	Anaplastic Oligodendroglioma	19.1%
60	Multiple Endocrine Neoplasia	19%
61	Acoustic Neuroma	18.6%
62	Leukemia, Radiation-Induced	18.5%
63	Cyst	18.2%
64	Neoplastic Processes	18.2%
65	Neoplastic Syndromes, Hereditary	18.2%
66	Pregnancy Complications, Neoplastic	18.2%
67	Choriocarcinoma	18.2%
68	Sarcoma 180	18.1%
69	Carcinoid Heart Disease	18.1%
70	Basal cell carcinoma	17.2%
71	Carcinoma, Papillary	17.2%
72	Squamous cell carcinoma	17.2%
73	Chondrosarcoma	17.2%
74	Cystadenoma	17.2%
75	leiomyosarcoma	17.2%
76	liposarcoma	17.2%
77	Mesothelioma	17.2%
78	synovial sarcoma	17.2%
79	Angiomyolipoma	17.2%
80	Clear Cell Sarcoma of Soft Tissue	17.2%
81	Alveolar Soft Part Sarcoma	17.2%
82	Sarcoma, Myeloid	17.2%
83	Carcinoma, Basal Cell	17.2%
84	melanoma	17%
85	Carcinoma, Lobular	16.4%
86	Glioblastoma	15.9%
87	Neuroblastoma	15.9%
88	Glioblastoma Multiforme	15.9%
89	Neoplasms, Radiation-Induced	15.9%
90	Thymoma	15.5%
91	Adenoma	15.5%
92	Ameloblastoma	15.5%
93	Angiokeratoma	15.5%
94	Carcinoma	15.5%
95	Hemangioma	15.5%
96	hemangiopericytoma	15.5%
97	Lymphangioma	15.5%
98	Mesenchymoma	15.5%
99	Hepatoblastoma	15.5%
100	Mixed Tumor, Mullerian	15.5%
101	Angiofibroma	15.5%
102	Sarcoma	15.5%
103	Epithelioma	15.5%
104	Tuberous Sclerosis	15.4%
105	Endometrial Stromal Sarcoma	15.1%
106	Acanthoma	14.9%
107	Cystadenocarcinoma	14.8%
108	Fibrosarcoma	14.8%
109	Osteosarcoma	14.8%
110	Mucoepidermoid Carcinoma	14.8%
111	Melanoma, Experimental	14.7%
112	Paraneoplastic Encephalomyelitis	14.6%
113	Nephroblastoma	14.4%
114	Ganglioneuroblastoma	14.2%
115	Neuroendocrine Tumors	13.7%
116	Vipoma	13.7%
117	Adenofibroma	13.6%
118	Fibroadenoma	13.6%
119	Malignant Fibrous Histiocytoma	13.6%
120	Plasmacytoma	13.3%
121	Lymphangioleiomyomatosis	13.3%
122	Malignant histiocytosis	13.3%
123	Histiocytic sarcoma	13.3%
124	Optic Nerve Glioma	13.2%
125	Neurofibrosarcoma	13.2%
126	Basal Cell Nevus Syndrome	13.1%
127	Dysgerminoma	12.7%
128	Neuroma	12.7%
129	Seminoma	12.7%
130	Lymphomatoid Granulomatosis	12.7%
131	Bowen's Disease	12.5%
132	Rhabdomyosarcoma	12.5%
133	Giant Cell Tumor of Bone	12.5%
134	Neoplasms, Experimental	12.3%
135	Multiple Endocrine Neoplasia Type 1	11.9%
136	Abdominal Neoplasms	11.8%
137	Erythroplasia	11.8%
138	Follicular cyst	11.8%
139	Head and Neck Neoplasms	11.8%
140	Mucocele	11.8%
141	Pilonidal Cyst	11.8%
142	Soft Tissue Neoplasms	11.8%
143	Thoracic Neoplasms	11.8%
144	Thyroglossal Cyst	11.8%
145	Synovial Cyst	11.8%
146	Aberrant Crypt Foci	11.8%
147	Carcinoma, Pancreatic Ductal	11.8%
148	Hodgkin Disease	11.6%
149	Lymphoma, Non-Hodgkin	11.6%
150	Dermatofibrosarcoma	11.3%
151	Dermatofibrosarcoma Protuberans	11.3%
152	Mesoblastic Nephroma	10.6%
153	Hydatidiform Mole	10.5%
154	Digestive System Neoplasms	10.5%
155	Endocrine Gland Neoplasms	10.5%
156	Eye Neoplasms	10.5%
157	Nervous System Neoplasms	10.5%
158	Primary amyloidosis	10.4%
159	Bone neoplasms	10.3%
160	Leukoplakia	10.3%
161	Lymphocele	10.3%
162	Pancreatic Cyst	10.3%
163	Skin Neoplasms	10.3%
164	Hematologic Neoplasms	10.3%
165	Barrett Esophagus	10.2%
166	Breast Cyst	10.2%
167	Actinic keratosis	10.2%
168	Mediastinal Cyst	10.2%
169	Neoplasm Invasiveness	10.2%
170	Neoplasm Metastasis	10.2%
171	Neoplasm Recurrence, Local	10.2%
172	Parovarian Cyst	10.2%
173	Pericardial Cyst	10.2%
174	Splenic Neoplasms	10.2%
175	Thymic Cyst	10.2%
176	Carcinogenesis	10.2%
177	Myxoid cyst	10.2%
178	Metastasis	10.2%
179	Hepatocellular Adenoma	10.2%
180	Alveolar rhabdomyosarcoma	10.1%
181	Adenocarcinoma	10%
182	Carcinoma in Situ	10%
183	Carcinoma, Transitional Cell	10%
184	Phyllodes Tumor	10%
185	Hemangioendothelioma	10%
186	Lipoma	10%
187	Myoma	10%
188	Myxoma	10%
189	Papilloma	10%
190	Pseudomyxoma Peritonei	10%
191	Papillomatosis	10%
192	Angiolipoma	10%
193	Myelolipoma	10%
194	Neoplasms, Bone Tissue	10%
195	Neoplasms, Fibrous Tissue	10%
196	Smooth Muscle Tumor	10%
197	Adenomatosis, Pulmonary	10%
198	Adenomatous Polyps	10%
199	Carcinoma, Large Cell	10%
200	Carcinoma, Small Cell	10%
201	Desmoplastic Small Round Cell Tumor	10%
202	Chondroma	10%
203	Enchondroma	10%
204	Parathyroid Neoplasms	10%
205	Peritoneal Neoplasms	10%
206	Thyroid Neoplasm	10%
207	Thyroid carcinoma	10%
208	Liver Cirrhosis, Experimental	9.8%
209	Arthritis, Experimental	9.8%
210	Adenomatous Polyposis Coli	9.6%
211	neurofibroma	9.5%
212	Prolactinoma	9.1%
213	Growth Hormone-Secreting Pituitary Adenoma	9.1%
214	Pancreatic Neoplasm	9.1%
215	Corpus Luteum Cyst	8.8%
216	Ovarian Cysts	8.8%
217	Diabetes Mellitus, Experimental	8.7%
218	Leukemia, Myelomonocytic, Chronic	8.6%
219	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	8.6%
220	Tracheal Neoplasms	8.5%
221	Waldenstrom Macroglobulinemia	8.5%
222	Multiple Myeloma	8.5%
223	Leukoplakia, Oral	8.4%
224	insulinoma	8.4%
225	Paraneoplastic Cerebellar Degeneration	8.3%
226	granulosa cell tumor	8.2%
227	Carcinoma, Ovarian Epithelial	8.2%
228	Choledochal Cyst	8%
229	Peutz-Jeghers Syndrome	7.8%
230	Mastocytosis	7.6%
231	Sturge-Weber Syndrome	7.6%
232	Gastrinoma	7.6%
233	Glucagonoma	7.6%
234	Gastrointestinal Stromal Tumors	7.6%
235	Esophageal Neoplasms	7.6%
236	Hemangioma, Cavernous	7.5%
237	Leukemia, T-Cell	7.5%
238	Leukemia, B-Cell	7.5%
239	Limbic Encephalitis	7.5%
240	Lymphoma, Follicular	7.5%
241	T-Cell Lymphoma	7.5%
242	Mantle cell lymphoma	7.5%
243	Leydig Cell Tumor	7.4%
244	Retroperitoneal Neoplasms	7.4%
245	Adenoid Cystic Carcinoma	7.3%
246	fibroma	7.3%
247	Fibromatosis	7.3%
248	Osteoblastoma	7.3%
249	Osteoma	7.3%
250	Rhabdomyoma	7.3%
251	Chondromatosis	7.3%
252	Adenocarcinoma, Clear Cell	7.3%
253	Cholangiocarcinoma	7.3%
254	Cervical Intraepithelial Neoplasia	7.3%
255	Hemangioblastoma	7.3%
256	Lymphoma, Extranodal NK-T-Cell	7.3%
257	Denys-Drash Syndrome	7.3%
258	Lambert-Eaton Myasthenic Syndrome	6.9%
259	Testicular Neoplasms	6.9%
260	Thyroid Nodule	6.9%
261	Radiation Injuries, Experimental	6.9%
262	Adrenocortical carcinoma	6.8%
263	Nasopharyngeal carcinoma	6.7%
264	Mouth Neoplasms	6.4%
265	Central Nervous System Neoplasms	6.4%
266	Vascular Neoplasms	6.4%
267	Thymus Neoplasms	6.4%
268	Opsoclonus-Myoclonus Syndrome	6.3%
269	Genital Neoplasms, Female	6.3%
270	Pancreatic Pseudocyst	6.3%
271	Lymphatic Metastasis	6.3%
272	Neoplasms, Unknown Primary	6.3%
273	Leukemic Infiltration	6.3%
274	Breast Neoplasms, Male	6.3%
275	Neoplasm Micrometastasis	6.3%
276	Triple Negative Breast Neoplasms	6.3%
277	Mastocytoma	6.3%
278	Mastocytosis, Systemic	6.2%
279	Leukemia, Myeloid, Chronic-Phase	6.2%
280	Renal Cell Carcinoma	6.1%
281	Papillary Renal Cell Carcinoma	6.1%
282	Fibromatosis, Aggressive	5.9%
283	Fibromatosis, Abdominal	5.9%
284	Klatskin Tumor	5.9%
285	Carcinoma, Endometrioid	5.8%
286	Myelitis, Transverse	5.8%
287	Adrenal Gland Neoplasms	5.6%
288	Gastrointestinal Neoplasms	5.6%
289	Genital Neoplasms, Male	5.6%
290	Liver neoplasms	5.6%
291	Uveal Neoplasms	5.6%
292	Urologic Neoplasms	5.6%
293	Sebaceous Gland Neoplasms	5.5%
294	Spinal Neoplasms	5.5%
295	Bone Marrow Neoplasms	5.5%
296	Xeroderma Pigmentosum	5.5%
297	Polycystic Ovary Syndrome	5.5%
298	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.4%
299	Leukemia, Large Granular Lymphocytic	5.4%
300	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.4%
301	Lymphoma, T-Cell, Cutaneous	5.4%
302	Lymphoma, AIDS-Related	5.4%
303	Enteropathy-Associated T-Cell Lymphoma	5.4%
304	Primary Effusion Lymphoma	5.4%
305	Nose Neoplasms	5.3%
306	Device Failure	5.1%
307	Neuritis, Autoimmune, Experimental	5.1%
308	Palatal Neoplasms	5%
309	Pituitary Adenoma	4.9%
310	Pituitary Neoplasms	4.9%
311	Cytogenetic Analysis	4.8%
312	Electrophoresis	4.8%
313	Dupuytren Contracture	4.5%
314	Urticaria Pigmentosa	4.5%
315	Intubation	4.5%
316	ovarian neoplasm	4.4%
317	Meningeal Neoplasms	4.4%
318	Mycosis Fungoides	4.4%
319	Lymphomatoid Papulosis	4.4%
320	Plasmablastic lymphoma	4.4%
321	Burkitt Lymphoma	4.4%
322	Myasthenia Gravis, Autoimmune, Experimental	4.1%
323	Ear Neoplasms	4%
324	Eyelid Neoplasms	4%
325	Lung Neoplasms	4%
326	Pleural Neoplasms	4%
327	Cell Transformation, Viral	3.9%
328	Brain Neoplasms	3.9%
329	Salivary Gland Neoplasms	3.9%
330	Spinal Cord Neoplasms	3.9%
331	Tongue Neoplasms	3.9%
332	Uterine Neoplasms	3.9%
333	Vaginal Neoplasms	3.9%
334	Vulvar Neoplasms	3.9%
335	Uterine Cancer	3.9%
336	Fallopian Tube Neoplasms	3.8%
337	Autopsy	3.8%
338	Microscopy	3.8%
339	Zollinger-Ellison syndrome	3.7%
340	Sezary Syndrome	3.6%
341	Pharyngeal Neoplasms	3.5%
342	Central Nervous System Cysts	3.5%
343	Meningeal Carcinomatosis	3.5%
344	Bile Duct Neoplasms	3.5%
345	gallbladder neoplasm	3.5%
346	Intestinal Neoplasms	3.5%
347	Penile Neoplasms	3.5%
348	Prostatic Neoplasms	3.5%
349	Stomach Neoplasms	3.5%
350	Polycythemia Vera	3.4%
351	Laryngeal neoplasm	3.2%
352	Bladder Neoplasm	3.1%
353	Kidney Neoplasm	3.1%
354	Ureteral Neoplasms	3.1%
355	Urethral Neoplasms	3.1%
356	Bronchial Neoplasms	3.1%
357	Multiple Pulmonary Nodules	3.1%
358	Supratentorial Neoplasms	3%
359	Endometrial Neoplasms	3%
360	Gastric Lavage	2.8%
361	Peritoneal lavage	2.8%
362	Bronchoalveolar Lavage	2.8%
363	Hypopharyngeal Neoplasms	2.7%
364	Pleural Effusion, Malignant	2.7%
365	Hypopharyngeal Cancer	2.7%
366	Parotid Neoplasms	2.7%
367	Prostatic Neoplasms, Castration-Resistant	2.7%
368	Nelson Syndrome	2.7%
369	Brain Stem Neoplasms	2.6%
370	Cecal Neoplasms	2.4%
371	Duodenal Neoplasms	2.4%
372	Choroid Plexus Papilloma	2.4%
373	Prosthesis Failure	2.4%
374	Immunosuppression	2.4%
375	Tonsillar Neoplasms	2.3%
376	Cerebellar Neoplasms	2.3%
377	Glasgow coma scale	2.3%
378	Nasopharyngeal Neoplasms	2.2%
379	Biopsy	2.2%
380	Colorectal Neoplasms	2.2%
381	Radicular Cyst	2.1%
382	Appendiceal Neoplasms	2.1%
383	Colonic Neoplasms	2.1%
384	Rectal Neoplasms	2.1%
385	Paranasal Sinus Neoplasms	2.1%
386	Amniocentesis	1.9%
387	Angioplasty	1.8%
388	Maxillary Sinus Neoplasms	1.8%
389	Anus Neoplasms	1.7%
390	Sigmoid Neoplasms	1.7%
391	Polymerase Chain Reaction	1.6%
392	Tuberculin Test	1.6%
393	Ovulation Induction	1.4%
394	Blood culture	1.4%
395	Immunoglobulin Therapy	1.4%
396	Leukapheresis	1.1%
397	Atherectomy	1.1%
398	Body mass index	1.1%
399	Paracentesis	0.9%
400	PROTHROMBIN TIME	0.8%
401	Glucose tolerance test	0.8%
402	Superovulation	0.8%
403	Clot retraction	0.8%
404	venipuncture	0.7%
405	Body Height	0.7%
406	Body Weight	0.7%
407	Birth Weight	0.5%
408	Fetal Weight	0.4%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262